Physical Activity and Survival After Prostate Cancer

European Urology

Volumn 70, Issue 4, 2016, Pages 576-585

  Friedenreich, Christine M ^a,b   Wang, Qinggang ^a   Neilson, Heather K ^a   Kopciuk, Karen A ^a,b,c   McGregor, S Elizabeth ^a,b   Courneya, Kerry S ^d  

^a ALBERTA HEALTH SERVICES   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Physical activity; Prospective cohort; Prostate cancer; Sedentary behaviour; Survival analysis

Indexed keywords

ADULT; AGED; ARTICLE; CANADA; CANCER GROWTH; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; COHORT ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY RISK; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; RECREATION; RISK REDUCTION; ALBERTA; CANCER STAGING; CAUSE OF DEATH; DISEASE EXACERBATION; EPIDEMIOLOGY; EXERCISE; FOLLOW UP; LIFESTYLE; METABOLIC EQUIVALENT; MORTALITY; PATHOLOGY; PHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; PROSTATE TUMOR; SELF REPORT; SURVIVAL RATE; TUMOR RECURRENCE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALBERTA; CAUSE OF DEATH; DISEASE PROGRESSION; EXERCISE; FOLLOW-UP STUDIES; HUMANS; LIFE STYLE; MALE; METABOLIC EQUIVALENT; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RECREATION; SELF REPORT; SURVIVAL RATE;

EID: 84983126561     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2015.12.032     Document Type: Article

References (30)

1. [1] Canadian Cancer Society's Advisory Committee on Cancer Statistics. Canadian cancer statistics 2015. Canadian Cancer Society Web site. https://www.cancer.ca/∼/media/cancer.ca/CW/cancer%20information/cancer%20101/Canadian%20cancer%20statistics/Canadian-Cancer-Statistics-2015-EN.pdf.
2. [2] International Agency for Research on Cancer and Cancer Research UK. World cancer factsheet. Cancer Research UK Web site. http://publications.cancerresearchuk.org/downloads/Product/CS_REPORT_WORLD.pdf.
3. [3] Kenfield, S.A., Stampfer, M.J., Giovannucci, E., Chan, J.M., Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study. J Clin Oncol 29 (2011), 726–732.
4. [4] Richman, E.L., Kenfield, S.A., Stampfer, M.J., Paciorek, A., Carroll, P.R., Chan, J.M., Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavor. Cancer Res 71 (2011), 3889–3895.
5. [5] Bonn, S.E., Sjolander, A., Lagerros, Y.T., et al. Physical activity and survival among men diagnosed with prostate cancer. Cancer Epidemiol Biomarkers Prev 24 (2015), 57–64.
6. [6] Friedenreich, C.M., McGregor, S.E., Courneya, K.S., Angyalfi, S.J., Elliott, F.G., Case-control study of lifetime total physical activity and prostate cancer risk. Am J Epidemiol 159 (2004), 740–749.
7. [7] Friedenreich, C.M., Courneya, K.S., Bryant, H.E., The lifetime total physical activity questionnaire: development and reliability. Med Sci Sports Exerc 30 (1998), 266–274.
8. [8] Block, G., Hartman, A.M., Dresser, C.M., Carroll, M.D., Gannon, J., Gardner, L., A data-based approach to diet questionnaire design and testing. Am J Epidemiol 124 (1986), 453–469.
9. [9] Friedenreich, C.M., Courneya, K.S., Neilson, H.K., et al. Reliability and validity of the Past Year Total Physical Activity Questionnaire. Am J Epidemiol 163 (2006), 959–970.
10. [10] American Joint Committee on Cancer. AJCC cancer staging manual. ed. 5, 1997, Lippincott-Raven, Philadelphia, PA.
11. [11] Ainsworth, B.E., Haskell, W.L., Herrmann, S.D., et al. 2011 Compendium of Physical Activities: a second update of codes and MET values. Med Sci Sports Exerc 43 ), 1575–1581.
12. [12] Li R, Hertzman E, Louie M, Chen L, Spiegelman D. SAS LGTPHCURV9 macro. Harvard School of Public Health Web site. http://www.hsph.harvard.edu/donna-spiegelman/software/lgtphcurv9/.
13. [13] Harrell, F.E. Jr., Lee, K.L., Pollock, B.G., Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst 80 (1988), 1198–1202.
14. [14] Fine, J.P., Gray, R.J., A proportional hazards model for the subdistribution of a competing risk. J Am Statist Assoc 94 (1999), 496–509.
15. [15] Rizopoulos, D., JM: An R package for the joint modelling of longitudinal and time-to-event data. J Stat Softw 35 (2010), 1–33.
16. [16] R Core Team. R: A language and environment for statistical computing. 3.0 ed., 2014, R Foundation for Statistical Computing, Vienna, Austria.
17. [17] Epstein, M.M., Edgren, G., Rider, J.R., Mucci, L.A., Adami, H.O., Temporal trends in cause of death among Swedish and US men with prostate cancer. J Natl Cancer Inst 104 (2012), 1335–1342.
18. [18] Shikanov, S., Kocherginsky, M., Shalhav, A.L., Eggener, S.E., Cause-specific mortality following radical prostatectomy. Prostate Cancer Prostatic Dis 15 (2012), 106–110.
19. [19] Scott, J.M., Koelwyn, G.J., Hornsby, W.E., et al. Exercise therapy as treatment for cardiovascular and oncologic disease after a diagnosis of early-stage cancer. Semin Oncol 40 (2013), 218–228.
20. [20] Cao, Y., Ma, J., Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res (Phila) 4 (2011), 486–501.
21. [21] Chalfin, H.J., Lee, S.B., Jeong, B.C., et al. Obesity and long-term survival after radical prostatectomy. J Urol 192 (2014), 1100–1104.
22. [22] Kenfield, S.A., Stampfer, M.J., Chan, J.M., Giovannucci, E., Smoking and prostate cancer survival and recurrence. JAMA 305 (2011), 2548–2555.
23. [23] Esser, K.A., Harpole, C.E., Prins, G.S., Diamond, A.M., Physical activity reduces prostate carcinogenesis in a transgenic model. Prostate 69 (2009), 1372–1377.
24. [24] Betof, A.S., Dewhirst, M.W., Jones, L.W., Effects and potential mechanisms of exercise training on cancer progression: a translational perspective. Brain Behav Immun 30:Suppl (2013), S75–S87.
25. [25] Wekesa, A., Harrison, M., Watson, R.W., Physical activity and its mechanistic effects on prostate cancer. Prostate Cancer Prostatic Dis 18 (2015), 197–207.
26. [26] Jones, L.W., Antonelli, J., Masko, E.M., et al. Exercise modulation of the host-tumor interaction in an orthotopic model of murine prostate cancer. J Appl Physiol (1985) 113 (2012), 263–272.
27. [27] Gardner, J.R., Livingston, P.M., Fraser, S.F., Effects of exercise on treatment-related adverse effects for patients with prostate cancer receiving androgen-deprivation therapy: a systematic review. J Clin Oncol 32 (2014), 335–346.
28. [28] Baumann, F.T., Zopf, E.M., Bloch, W., Clinical exercise interventions in prostate cancer patients–a systematic review of randomized controlled trials. Support Care Cancer 20 (2012), 221–233.
29. [29] Winters-Stone, K.M., Beer, T.M., Review of exercise studies in prostate cancer survivors receiving androgen deprivation therapy calls for an aggressive research agenda to generate high-quality evidence and guidance for exercise as standard of care. J Clin Oncol 32 (2014), 2518–2519.
30. [30] Chan, J.M., Van Blarigan, E.L., Kenfield, S.A., What should we tell prostate cancer patients about (secondary) prevention?. Curr Opin Urol 24 (2014), 318–323.